Grand Pharma’s Global Innovative Product STC3141 Achieved the Clinical Endpoint of The Phase Ib Clinical Trial for the Treatment of ARDS in China
According to the data analysis of the clinical trial, in the primary endpoint of the study, STC3141 did not suggest...


















